In recent years, the concept of deprescribing has been introduced, based on the reduction of the number of drugs taken in order to optimize the risk-benefit ratio of polypharmacy taking into account the goals of treatment and the preferences of the patient; however, the available intervention strategies are not numerous.1
The FDA is evaluating the potential risk of exposure to toxic compounds when using certain Fresenius Medical Care hemodialysis machines
Thu, 05 May 2022 10:30:13 -0400
Thu, 05 May 2022 09:46:46 -0400
Thu, 05 May 2022 09:46:44 -0400
Wed, 04 May 2022 11:28:15 -0400
As it often happens - even if it is not always apparent - a single “fil rouge” indissolubly links researchers, pediatricians and children. We are talking about the so-called off-label drugs that represent about 50% of potential prescriptions in the pediatric age.
Mon, 02 May 2022 09:58:21 -0400
Mon, 02 May 2022 09:46:03 -0400
Mon, 02 May 2022 09:46:03 -0400
80.211.154.110
